Literature DB >> 9785512

Development of a mouse model system, coding assignments and identification of the genome segments controlling virulence of African horse sickness virus serotypes 3 and 8.

R S O'Hara1, A J Meyer, J N Burroughs, L Pullen, L A Martin, P P Mertens.   

Abstract

Attenuated (att) and wild type (wt) strains of the nine AHSV serotypes were evaluated for virulence in adult Balb C mice. Although most were avirulent in this system, isolates of AHSV 1att, 3wt, 3att, 4wt, 5att, 7att and 8att caused some mortality when administered via an intranasal route. After plaque cloning, only the attenuated vaccine strain of AHSV 7att caused any mortality via an intravenous route. AHSV 3att and AHSV 8wt were virulent (V) and avirulent (AV) (respectively) in the mouse model and were selected as parental strains for production of genome segment reassortants. These progeny virus strains were plaque cloned, then characterised to identify the genome segments that influence virulence of AHSV in the mouse model. Three virulence phenotypes were observed: fully virulent (V); fully avirulent (A); and a novel intermediate virulence (N) not expressed by either parental strain. Genome segment 2 (encoding outer capsid protein VP2) from the avirulent parent appeared to have a controlling influence in production of the A phenotype. Reassortants with the V phenotype all contained segment 2 from the virulent parent, however in each case they also contained genome segments 5 and 10, also from AHSV 3 (V). Genome segments 5 and 10 encode the smaller outer capsid protein VP5 and the non structural proteins NS3/NS3a, respectively. A combination of genome segments 2, 5 and 6 from the avirulent parent and segment 10 from the virulent parent were found in each of the virus strains with the N phenotype. However, comparison of two reassortants (A79 and A790), which differ only in a single segment, showed that replacement of genome segment 10 from the avirulent parent with that from the virulent parent, conferred the N phenotype on A790.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9785512     DOI: 10.1007/978-3-7091-6823-3_23

Source DB:  PubMed          Journal:  Arch Virol Suppl        ISSN: 0939-1983


  11 in total

1.  Intragenic recombination as a mechanism of genetic diversity in bluetongue virus.

Authors:  Cheng-Qiang He; Nai-Zheng Ding; Mei He; Shan-Ni Li; Xing-Ming Wang; Hong-Bin He; Xin-Fa Liu; Hong-Shan Guo
Journal:  J Virol       Date:  2010-08-11       Impact factor: 5.103

2.  Turnover Rate of NS3 Proteins Modulates Bluetongue Virus Replication Kinetics in a Host-Specific Manner.

Authors:  Najate Ftaich; Claire Ciancia; Cyril Viarouge; Gerald Barry; Maxime Ratinier; Piet A van Rijn; Emmanuel Breard; Damien Vitour; Stephan Zientara; Massimo Palmarini; Christophe Terzian; Frédérick Arnaud
Journal:  J Virol       Date:  2015-08-05       Impact factor: 5.103

3.  Determinants of bluetongue virus virulence in murine models of disease.

Authors:  Marco Caporale; Rachael Wash; Attilio Pini; Giovanni Savini; Paola Franchi; Matthew Golder; Janet Patterson-Kane; Peter Mertens; Luigina Di Gialleonardo; Gisella Armillotta; Rossella Lelli; Paul Kellam; Massimo Palmarini
Journal:  J Virol       Date:  2011-08-24       Impact factor: 5.103

4.  A modified vaccinia Ankara virus (MVA) vaccine expressing African horse sickness virus (AHSV) VP2 protects against AHSV challenge in an IFNAR -/- mouse model.

Authors:  Javier Castillo-Olivares; Eva Calvo-Pinilla; Isabel Casanova; Katarzyna Bachanek-Bankowska; Rachael Chiam; Sushila Maan; Jose Maria Nieto; Javier Ortego; Peter Paul Clement Mertens
Journal:  PLoS One       Date:  2011-01-26       Impact factor: 3.240

5.  Detection of a fourth orbivirus non-structural protein.

Authors:  Mourad Belhouchet; Fauziah Mohd Jaafar; Andrew E Firth; Jonathan M Grimes; Peter P C Mertens; Houssam Attoui
Journal:  PLoS One       Date:  2011-10-12       Impact factor: 3.240

6.  Serotype specific primers and gel-based RT-PCR assays for 'typing' African horse sickness virus: identification of strains from Africa.

Authors:  Narender S Maan; Sushila Maan; Kyriaki Nomikou; Manjunatha N Belaganahalli; Katarzyna Bachanek-Bankowska; Peter P C Mertens
Journal:  PLoS One       Date:  2011-10-20       Impact factor: 3.240

Review 7.  Adaptive strategies of African horse sickness virus to facilitate vector transmission.

Authors:  Anthony Wilson; Philip Scott Mellor; Camille Szmaragd; Peter Paul Clement Mertens
Journal:  Vet Res       Date:  2008-12-19       Impact factor: 3.683

8.  Reassortment between two serologically unrelated bluetongue virus strains is flexible and can involve any genome segment.

Authors:  Andrew E Shaw; Maxime Ratinier; Sandro Filipe Nunes; Kyriaki Nomikou; Marco Caporale; Matthew Golder; Kathryn Allan; Claude Hamers; Pascal Hudelet; Stéphan Zientara; Emmanuel Breard; Peter Mertens; Massimo Palmarini
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

9.  Real time RT-PCR assays for detection and typing of African horse sickness virus.

Authors:  Katarzyna Bachanek-Bankowska; Sushila Maan; Javier Castillo-Olivares; Nicola M Manning; Narender Singh Maan; Abraham C Potgieter; Antonello Di Nardo; Geoff Sutton; Carrie Batten; Peter P C Mertens
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

Review 10.  Transboundary Animal Diseases, an Overview of 17 Diseases with Potential for Global Spread and Serious Consequences.

Authors:  Elizabeth A Clemmons; Kendra J Alfson; John W Dutton
Journal:  Animals (Basel)       Date:  2021-07-08       Impact factor: 2.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.